121 related articles for article (PubMed ID: 8395357)
21. Low-dose mercury heightens early innate response to coxsackievirus infection in female mice.
Penta KL; Fairweather D; Shirley DL; Rose NR; Silbergeld EK; Nyland JF
Inflamm Res; 2015 Jan; 64(1):31-40. PubMed ID: 25376339
[TBL] [Abstract][Full Text] [Related]
22. Laboratory diagnosis of viral myocarditis. A review.
Shingu M
Jpn Circ J; 1989 Jan; 53(1):87-93. PubMed ID: 2541266
[TBL] [Abstract][Full Text] [Related]
23. Role of IL-1 and tumor necrosis factor in coxsackie virus-induced autoimmune myocarditis.
Lane JR; Neumann DA; Lafond-Walker A; Herskowitz A; Rose NR
J Immunol; 1993 Aug; 151(3):1682-90. PubMed ID: 8335952
[TBL] [Abstract][Full Text] [Related]
24. Demonstration of suppressor cells in coxsackievirus group B, type 3 infected female Balb/c mice which prevent myocarditis.
Job LP; Lyden DC; Huber SA
Cell Immunol; 1986 Mar; 98(1):104-13. PubMed ID: 3017580
[TBL] [Abstract][Full Text] [Related]
25. Coxsackievirus B-3 myocarditis. T-cell autoimmunity to heart antigens is resistant to cyclosporin-A treatment.
Estrin M; Smith C; Huber S
Am J Pathol; 1986 Nov; 125(2):244-51. PubMed ID: 3024491
[TBL] [Abstract][Full Text] [Related]
26. Immunopathogenesis of experimental Coxsackievirus induced myocarditis: role of autoimmunity.
Huber SA; Lyden DC; Lodge PA
Herz; 1985 Feb; 10(1):1-7. PubMed ID: 2984097
[TBL] [Abstract][Full Text] [Related]
27. In vivo significance of T cells in the development of Coxsackievirus B3 myocarditis in mice. Immature but antigen-specific T cells aggravate cardiac injury.
Kishimoto C; Abelmann WH
Circ Res; 1990 Sep; 67(3):589-98. PubMed ID: 1697791
[TBL] [Abstract][Full Text] [Related]
28. Molecular mimicry, anti-coxsackievirus B3 neutralizing monoclonal antibodies, and myocarditis.
Gauntt CJ; Arizpe HM; Higdon AL; Wood HJ; Bowers DF; Rozek MM; Crawley R
J Immunol; 1995 Mar; 154(6):2983-95. PubMed ID: 7533190
[TBL] [Abstract][Full Text] [Related]
29. Treatment of coxsackievirus-B3-infected BALB/c mice with the soluble coxsackie adenovirus receptor CAR4/7 aggravates cardiac injury.
Dörner A; Grunert HP; Lindig V; Chandrasekharan K; Fechner H; Knowlton KU; Isik A; Pauschinger M; Zeichhardt H; Schultheiss HP
J Mol Med (Berl); 2006 Oct; 84(10):842-51. PubMed ID: 16924471
[TBL] [Abstract][Full Text] [Related]
30. Coxsackievirus-B3-induced myocarditis: virus receptor antibodies modulate myocarditis.
Weller AH; Simpson K; Herzum M; Van Houten N; Huber SA
J Immunol; 1989 Sep; 143(6):1843-50. PubMed ID: 2550544
[TBL] [Abstract][Full Text] [Related]
31. Coxsackievirus induced myocarditis in mice: cardiac myosin autoantibodies do not cross-react with the virus.
Neu N; Craig SW; Rose NR; Alvarez F; Beisel KW
Clin Exp Immunol; 1987 Sep; 69(3):566-74. PubMed ID: 3665185
[TBL] [Abstract][Full Text] [Related]
32. Interleukin-27 ameliorates coxsackievirus-B3-induced viral myocarditis by inhibiting Th17 cells.
Zhu H; Lou C; Liu P
Virol J; 2015 Nov; 12():189. PubMed ID: 26578236
[TBL] [Abstract][Full Text] [Related]
33. AIM2 Co-immunization with VP1 Is Associated with Increased Memory CD8 T Cells and Mounts Long Lasting Protection against Coxsackievirus B3 Challenge.
Yin L; Chai D; Yue Y; Dong C; Xiong S
Front Cell Infect Microbiol; 2017; 7():247. PubMed ID: 28642849
[TBL] [Abstract][Full Text] [Related]
34. Distinct Th17 inductions contribute to the gender bias in CVB3-induced myocarditis.
Li Z; Yue Y; Xiong S
Cardiovasc Pathol; 2013; 22(5):373-82. PubMed ID: 23523188
[TBL] [Abstract][Full Text] [Related]
35. Cytokine production by Vgamma(+)-T-cell subsets is an important factor determining CD4(+)-Th-cell phenotype and susceptibility of BALB/c mice to coxsackievirus B3-induced myocarditis.
Huber SA; Graveline D; Born WK; O'Brien RL
J Virol; 2001 Jul; 75(13):5860-9. PubMed ID: 11390587
[TBL] [Abstract][Full Text] [Related]
36. Anti-idiotype-pulsed B cells in the induction and expression of autoimmune myocarditis.
Paque RE; Miller R
Clin Immunol Immunopathol; 1993 Aug; 68(2):111-7. PubMed ID: 8395356
[No Abstract] [Full Text] [Related]
37. Role of CD1d in coxsackievirus B3-induced myocarditis.
Huber S; Sartini D; Exley M
J Immunol; 2003 Mar; 170(6):3147-53. PubMed ID: 12626572
[TBL] [Abstract][Full Text] [Related]
38. [Role of Coxsackie group B viral infection in nonrheumatic myocarditis and recurrent rheumocarditis].
Nunaev VL; Novikov IuI; Stulova MA; Lavrova IK
Vopr Revm; 1979; (4):24-8. PubMed ID: 230637
[No Abstract] [Full Text] [Related]
39. Coxsackie B viruses and autoimmune diabetes.
Vague P; Vialettes B; Prince MA; de Micco P
N Engl J Med; 1981 Nov; 305(19):1157-8. PubMed ID: 6270551
[No Abstract] [Full Text] [Related]
40. Expression of immunoregulatory cytokines by recombinant coxsackievirus B3 variants confers protection against virus-caused myocarditis.
Henke A; Zell R; Ehrlich G; Stelzner A
J Virol; 2001 Sep; 75(17):8187-94. PubMed ID: 11483764
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
